Intrinsiqq
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc.

CTXR

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$13M
EPS-$1.68
P/E-0.29
P/FCF-0.38
EV/EBITDA-4.84
FCF Yield–
Div. Yield–
Net Debt/FCF-8.1x
Citius Pharmaceuticals, Inc. intrinsic value
52-Week Range
$0.37$1.44

Profitability & Returns

Revenue

N/A

Net Income (TTM)

-$45M

▲ +6.8% YoY

Op. Margin

–

ROIC

-13.12%

▲ +27.2pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$35M

▲ +5.8% YoY

Op. Cash Flow (TTM)

-$35M

▲ +5.8% YoY

Net Debt

$284M

Cash & Equiv.

$17M

5Y CAGR: +12.5%

Continue Research

Peers

Pharmaceutical Preparations · Pick stocks to compare with CTXR

CompareIntrinsic value
HCWBHCW Biologics Inc.
$0.75+1.90%15
CUECue Biopharma, Inc.
$4.15-7.78%40
BYSIBeyondSpring Inc.
$0.33-24.49%20
CAPRCapricor Therapeutics Inc.
$7.59+0.80%10
MGNXMacrogenics Inc.
$1.96-1.01%28
VREOFVireo Growth Inc.
$5.23-2.24%30
NKTRNektar Therapeutics Inc.
$30.20-7.19%25
PTIXProtagenic Therapeutics, Inc.
$0.42-0.71%20

Citius Pharmaceuticals (CTXR) in three numbers

Quality score
0/100
Best check: revenue growth, 0.0%.
Quality
Dividend
None
No dividend in the SEC filings we hold.
Dividends
P/E
-0.29
Negative: a loss over the last twelve months. Price to free cash flow -0.38.
Financials

Questions about Citius Pharmaceuticals

Is Citius Pharmaceuticals a high-quality business?

Citius Pharmaceuticals scores 0 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is revenue growth at 0.0%. The Quality tab shows every check against its target.

Does Citius Pharmaceuticals (CTXR) pay a dividend?

No. Citius Pharmaceuticals (CTXR) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: 10-Q filed 13 Aug 2026 (period ending 30 Jun 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong? Check it in CTXR's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CTXR

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.